Bank of New York Mellon’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-3,497
| Closed | -$74K | – | 4720 |
|
|
2022
Q1 | $74K | Sell |
3,497
-139
| -4% | -$2.94K | ﹤0.01% | 4460 |
|
|
2021
Q4 | $219K | Sell |
3,636
-2,220
| -38% | -$134K | ﹤0.01% | 4242 |
|
|
2021
Q3 | $550K | Buy |
5,856
+190
| +3% | +$17.8K | ﹤0.01% | 3758 |
|
|
2021
Q2 | $938K | Buy |
5,666
+337
| +6% | +$55.8K | ﹤0.01% | 3458 |
|
|
2021
Q1 | $1.03M | Buy |
+5,329
| New | +$1.03M | ﹤0.01% | 3312 |
|